Loading…

Valion Bio Inc Is A Late-Stage Biopharmaceutical Company Developing Biologics That Activate Innate Immune Pathways For Cytoprotection And Immune Modulation. Its Main Candidate, Entolimod, Is A Tlr5 Agonist And Also Advances Entolasta, A Next-Generation Tlr5 Agonist, And Targets The Neutropenia Oncology Supportive Care Market.